Chemoradiotherapy Offers Potential Organ-Preserving Option for Early Rectal Cancer

Initial results published in The Lancet Oncology indicate that a novel chemoradiotherapy approach may allow many patients with early-stage rectal cancer to avoid major surgery. This organ-preserving treatment aims to significantly reduce the lasting side effects typically associated with standard surgical interventions, potentially improving patient quality of life.